Pharmacia starts IOL (intra-ocular lenses) plant in India:
This article was originally published in Clinica
Pharmacia & Upjohn is setting up a plant in Bangalore, India, to manufacture one-piece intra-ocular lenses (IOLs). The company will spend $8.8 million on the factory, which is part of Pharmacia's expansion plans in India. The company started in India a year ago and now employs some 250 people. Indian surgeons presently use the three-piece IOL and the one-piece is considered a good alternative, according to Pharmacia.
You may also be interested in...
After two Indian vaccine makers, Serum Institute of India and Cadila Healthcare joined the fight against COVID-19, Bharat Biotech may follow suit. Others like Hilleman have decided against it for the moment while Panacea Biotech is weighing the pros and cons of developing a SARS-CoV-2 vaccine after a sour experience with H1N1.
South Korea’s HLB has begun a new growth phase by taking over US-based clinical stage biotech firm Immunomic Therapeutics. Through the acquisition, it is poised to add new pipeline assets including a Phase II vaccine therapy for glioblastoma and proprietary lysosomal targeting technology.